Search Browse Earnings

Kezar Life Sciences, Inc. — SlamSEC

Kezar Life Sciences, Inc.

Nasdaq:KZR

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$70.1M

FY 2024

Net Income

-$68.2M

FY 2024

EPS (Diluted)

-$10.13

FY 2024

Stock Price

$6.85

-4.6%

2026-03-13

52W Range

$3.53 – $7.45

P/E Ratio

-0.7x

Market Cap

$50.2M

Cash

$35.5M

FY 2024

Total Debt

$10.1M

FY 2024

Net Cash

$25.4M

FY 2024

Enterprise Value

$24.7M

Debt / EBITDA

0.4x

FY 2024

EV / EBITDA

-0.4x

Employees

—